Raymond James Financial Services Advisors’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Raymond James Financial Services Advisors’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-36,079	Closed	-$769K	–	3550
2024 Q1	$769K	Buy	36,079 +4,934	+16%	+$59K	﹤0.01%	2220
2023 Q4	$299K	Buy	+31,145	New	+$151K	﹤0.01%	2741

Raymond James Financial Services Advisors's FUSN Position: Q2 2024 in Review

Raymond James Financial Services Advisors sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 36,079 shares — an estimated $769K sold.

Raymond James Financial Services Advisors first reported a position in FUSN in Q4 2023 and held it in 2 quarters. The position peaked at $769K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Raymond James Financial Services Advisors reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Raymond James Financial Services Advisors sold 36,079 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $769K.
Raymond James Financial Services Advisors first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q4 2023 and held it in 2 quarters.
Raymond James Financial Services Advisors's Fusion Pharmaceuticals Inc. Common Shares position peaked at $769K in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q2 2024, filed 19 Jul 2024.